The European Medicines Agency (EMA) has recently approved the world's first malaria vaccine. The vaccine is called RTS,S and is being sold under the trade name Mosquirix. Many were saddened to hear the shot only has an effectiveness range of 25-50%, with effectiveness increasing as the age of the child the vaccine is being administered to is increased. However it is being rolled out to be used in babies at risk of getting malaria in African countries, as Mosquirix has the most promising results so far.
No comments:
Post a Comment